9780990449119-0990449114-Epidemiology and Prevention of Vaccine-Preventable Diseases

Epidemiology and Prevention of Vaccine-Preventable Diseases

ISBN-13: 9780990449119
ISBN-10: 0990449114
Edition: 13
Author: CDC
Publication date: 2015
Publisher: PUBLIC HEALTH FOUNDATION
Format: Paperback 512 pages
FREE US shipping

Book details

ISBN-13: 9780990449119
ISBN-10: 0990449114
Edition: 13
Author: CDC
Publication date: 2015
Publisher: PUBLIC HEALTH FOUNDATION
Format: Paperback 512 pages

Summary

Epidemiology and Prevention of Vaccine-Preventable Diseases (ISBN-13: 9780990449119 and ISBN-10: 0990449114), written by authors CDC, was published by PUBLIC HEALTH FOUNDATION in 2015. With an overall rating of 4.3 stars, it's a notable title among other Internal Medicine (Medicine) books. You can easily purchase or rent Epidemiology and Prevention of Vaccine-Preventable Diseases (Paperback) from BooksRun, along with many other new and used Internal Medicine books and textbooks. And, if you're looking to sell your copy, our current buyback offer is $0.43.

Description

Developed by the Centers for Disease Control and Prevention's (CDC) National Center for Immunization and Respiratory Diseases and published by the Public Health Foundation, this edition provides updated immunization and vaccine information to public health practitioners, healthcare providers, health educators, pharmacists, nurses, and others involved in administering immunizations. Current, credible, and comprehensive, "The Pink Book" contains information on each vaccine-preventable disease and delivers immunization providers with the latest information on: Principles of vaccination General recommendations on immunization Vaccine safety Child/adult immunization schedules International vaccines/Foreign language terms Vaccination data and statistics The 13th Edition offers an easy-to-read format for immunization professionals to use and reference. Updates include: New vaccine administration guidelines New recommendations regarding selection of storage and temperature monitoring tools New recommendations for vaccine transport Updated information on available influenza vaccine products Use of Tdap in pregnancy Use of Tdap in persons 65 years of age or older Use of PCV13 and PPSV23 in adults with immunocompromising conditions New licensure information for varicella-zoster immune globulin

Rate this book Rate this book

We would LOVE it if you could help us and other readers by reviewing the book